An objective statistical model was derived to predict CFS status based only on the proteomic detection of keratin 16, α-2-macroglobulin, orosomucoid 2, autotaxin, and pigment epithelium-derived factor. The gene discussed is KRT16; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.